Supplementary Figure 4 from Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
Year: 2023
Type: supplementary-materials
Abstract: PDF file - 22K, Targeting the tdLN with NP-OVA and NP-CpG induces more antigen-specific and effector CD8+ T cells in the tumor, spleen, and tdLN.
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362568457
